44
Participants
Start Date
February 14, 2019
Primary Completion Date
January 22, 2021
Study Completion Date
January 22, 2021
Valeda PBM treatment
The Valeda Light Delivery System delivers 590, 660 and 850 nm wavelengths of light to the study eye. The Valeda Light Delivery System will treat through the open eyelid with the 590 nm and 850 nm wavelengths together. The 660 nm wavelength will be treated through the closed eyelid.
Valeda Sham treatment
The sham mode emits an approximate 100x reduction in the highest dose for the 660 nm wavelengths as compared to the treatment mode, producing a slightly duller light. The 850 nm (NIR) wavelength (which is not visible light) is not provided in the sham treatment.
Universitaetsmedizin Mainz- Augenklinik, Mainz
Universitätsklinikum Freiburg- Klinik für Augenheilkunde, Freiburg im Breisgau
Institut ophtalmologique de l'Ouest- Clinique jules VERNE, Nantes
Klinik fur Ophthalmologie, Universitatsklinikum Schleswig-Holstein, Kiel
Osprdalr San Raffaele, Milan
Institut Català de Retina, Barcelona
James Paget University, Great Yarmouth
Peterborough City Hospital, Peterborough
Lead Sponsor
LumiThera, Inc.
INDUSTRY